Market Closed -
Nasdaq Stockholm
11:29:30 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
342
SEK
|
+1.18%
|
|
+7.55%
|
-14.50%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,174
|
4,619
|
4,528
|
3,826
|
-
|
-
|
Enterprise Value (EV)
1 |
5,174
|
4,912
|
4,825
|
3,992
|
3,860
|
3,714
|
P/E ratio
|
1,235
x
|
30.4
x
|
32.3
x
|
27.3
x
|
19.8
x
|
17.6
x
|
Yield
|
-
|
0.67%
|
0.75%
|
0.73%
|
1.01%
|
1.14%
|
Capitalization / Revenue
|
-
|
3.45
x
|
3.22
x
|
2.75
x
|
2.52
x
|
2.33
x
|
EV / Revenue
|
-
|
3.67
x
|
3.43
x
|
2.87
x
|
2.54
x
|
2.27
x
|
EV / EBITDA
|
-
|
18.9
x
|
18.5
x
|
15.1
x
|
12.8
x
|
11.2
x
|
EV / FCF
|
-
|
29.1
x
|
42.2
x
|
22.1
x
|
21.2
x
|
17.9
x
|
FCF Yield
|
-
|
3.44%
|
2.37%
|
4.53%
|
4.71%
|
5.57%
|
Price to Book
|
-
|
6.65
x
|
5.62
x
|
4.17
x
|
3.53
x
|
3.03
x
|
Nbr of stocks (in thousands)
|
11,321
|
11,321
|
11,321
|
11,321
|
-
|
-
|
Reference price
2 |
457.0
|
408.0
|
400.0
|
338.0
|
338.0
|
338.0
|
Announcement Date
|
2/24/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,339
|
1,408
|
1,392
|
1,521
|
1,640
|
EBITDA
1 |
-
|
260.6
|
261.3
|
265
|
302
|
332.3
|
EBIT
1 |
-
|
220
|
214.6
|
216.5
|
258.7
|
287.3
|
Operating Margin
|
-
|
16.43%
|
15.24%
|
15.56%
|
17.01%
|
17.52%
|
Earnings before Tax (EBT)
1 |
-
|
196.9
|
180.2
|
185
|
251
|
282
|
Net income
1 |
4.145
|
151.8
|
140.2
|
140.3
|
193.1
|
217.4
|
Net margin
|
-
|
11.33%
|
9.96%
|
10.08%
|
12.69%
|
13.26%
|
EPS
2 |
0.3700
|
13.40
|
12.39
|
12.39
|
17.05
|
19.20
|
Free Cash Flow
1 |
-
|
169
|
114.2
|
181
|
182
|
207
|
FCF margin
|
-
|
12.62%
|
8.11%
|
13.01%
|
11.96%
|
12.62%
|
FCF Conversion (EBITDA)
|
-
|
64.84%
|
43.71%
|
68.29%
|
60.26%
|
62.3%
|
FCF Conversion (Net income)
|
-
|
111.34%
|
81.46%
|
129.05%
|
94.27%
|
95.22%
|
Dividend per Share
2 |
-
|
2.750
|
3.000
|
2.478
|
3.411
|
3.840
|
Announcement Date
|
2/24/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
350.7
|
326.4
|
340.1
|
358.8
|
353
|
354.7
|
341.9
|
342
|
345
|
349
|
355
|
EBITDA
1 |
73.37
|
67.25
|
57.8
|
68.17
|
71.34
|
73.75
|
48.07
|
61
|
64
|
71
|
69
|
EBIT
1 |
63.38
|
57.33
|
47.35
|
57.83
|
60.72
|
61.59
|
34.5
|
49
|
52
|
59
|
57
|
Operating Margin
|
18.07%
|
17.56%
|
13.92%
|
16.12%
|
17.2%
|
17.37%
|
10.09%
|
14.33%
|
15.07%
|
16.91%
|
16.06%
|
Earnings before Tax (EBT)
1 |
56.01
|
52.5
|
39.9
|
50.68
|
59.42
|
51.88
|
18.24
|
39
|
43
|
52
|
51
|
Net income
1 |
42.49
|
43.15
|
27.48
|
38.8
|
-
|
-
|
16.36
|
29
|
32
|
40
|
39
|
Net margin
|
12.12%
|
13.22%
|
8.08%
|
10.81%
|
-
|
-
|
4.78%
|
8.48%
|
9.28%
|
11.46%
|
10.99%
|
EPS
|
3.750
|
-
|
2.430
|
3.430
|
4.030
|
3.480
|
1.440
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/17/22
|
11/11/22
|
2/22/23
|
5/16/23
|
8/17/23
|
10/30/23
|
2/20/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
293
|
297
|
166
|
34
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
112
|
Leverage (Debt/EBITDA)
|
-
|
1.125
x
|
1.136
x
|
0.6263
x
|
0.1126
x
|
-
|
Free Cash Flow
1 |
-
|
169
|
114
|
181
|
182
|
207
|
ROE (net income / shareholders' equity)
|
-
|
24.8%
|
18.7%
|
16.3%
|
19.3%
|
18.5%
|
ROA (Net income/ Total Assets)
|
-
|
9.72%
|
8.4%
|
8.09%
|
10.3%
|
10.5%
|
Assets
1 |
-
|
1,562
|
1,669
|
1,733
|
1,881
|
2,074
|
Book Value Per Share
2 |
-
|
61.30
|
71.20
|
81.10
|
95.70
|
111.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
27.2
|
21.6
|
17.9
|
36.4
|
39.8
|
Capex / Sales
|
-
|
2.03%
|
1.53%
|
1.29%
|
2.39%
|
2.43%
|
Announcement Date
|
2/24/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -11.25% | 349M | | +10.82% | 8.72B | | +36.64% | 2.17B | | -8.11% | 1.09B | | +1.18% | 837M | | +8.53% | 768M | | -11.56% | 624M | | +6.85% | 610M | | +7.54% | 622M | | -4.66% | 577M |
Purification & Treatment Equipment
|